search
Back to results

Recovery Support for Bladder Cancer Patients and Caregivers

Primary Purpose

Bladder Cancer, Patient Engagement, Patient Empowerment

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cancer Resource Information Support (CRIS)
Usual Care Enhanced
Sponsored by
Northwell Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Bladder Cancer focused on measuring patient focused intervention, caregiver, Internet based information, recovery support, bladder cancer, urinary diversion, neobladder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • (a) male or female patients diagnosed with BC
  • (b) undergoing bladder removal surgery and one of the following urinary diversions: 1) ileal conduit, 2) neobladder or 3) Indiana pouch.
  • (c) did not need or completed neo-adjuvant chemotherapy,
  • (d) able to communicate with ease in English

Exclusion Criteria:

  • (a) the caregiving relationship is temporary (e.g., an out-of-town relative provides temporary support) as stated by both patient and caregiver.

Sites / Locations

  • Northwell HealthRecruiting
  • Fox Chase Cancer CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Usual care enhanced

Intervention

Arm Description

Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.

Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.

Outcomes

Primary Outcome Measures

Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
The Caregiver Quality of Life Index-C
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
The Caregiver Quality of Life Index-C
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
The Caregiver Quality of Life Index-C
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
The Caregiver Quality of Life Index-C
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
The Caregiver Quality of Life Index-C

Secondary Outcome Measures

Infection rate (biological factor)
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Infection rate (biological factor)
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Infection rate (biological factor)
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Infection rate (biological factor)
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Visiting Nurse/ER visits
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Visiting Nurse/ER visits
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Visiting Nurse/ER visits
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Visiting Nurse/ER visits
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review

Full Information

First Posted
July 22, 2019
Last Updated
May 10, 2023
Sponsor
Northwell Health
Collaborators
Fox Chase Cancer Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04055311
Brief Title
Recovery Support for Bladder Cancer Patients and Caregivers
Official Title
Recovery Support for Bladder Cancer Patients and Caregivers: A Multimodal Approach
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northwell Health
Collaborators
Fox Chase Cancer Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
For patients with certain types of bladder cancer, the removal of the bladder and the construction of an artificial bladder or reservoir are the only treatment options. Both before and after treatment, patients and caregivers face profound challenges preparing for surgery and planning for tasks during their recovery. To aid in recovery and enhance quality of life this program of research will develop and evaluate a multi-stage intervention geared towards patients and their caregivers. Part 1 of this program will have a nurse or trained health professional prepare both patients and their caregivers before treatment about the upcoming surgery. During this time the nurse will also demonstrate the necessary tools and techniques for stoma care. In addition, patients and their caregivers will receive access to a recovery website, specifically designed for bladder cancer patients to be used as a resource for after treatment. The website will be part 2 of this research and will contain important recovery information, videos about post-surgical care, testimonials by other patients and physicians and a variety of other resources. Patients and caregivers in the control group will receive the Facing Forward brochures from the National Cancer Institute in part 2. This research has been funded by the National Cancer Institute and will be the first study to address the needs of bladder cancer patients and their caregivers. The ultimate goal of the study is to reduce infections and unplanned nurse/ER visits and improve quality of life for both patients and their caregivers. This new program will be evaluated over the course of 12-months and if found successful, has the potential to be disseminated throughout the health care systems of the two study sites.
Detailed Description
Treatment for certain types of bladder cancer (BC) involves the removal of the bladder and construction of a new voiding system and is physically and psychologically profoundly challenging for patients and caregivers. Based on investigators' published literature and extensive pilot data, patients and caregivers have extensive unmet informational, social, psychological, instrumental, and medical needs from the time of diagnosis, through treatment and recovery which are not adequately addressed by health care professionals. Investigators propose to address these unmet needs through the refinement and evaluation of a comprehensive, 2-part (in-person and web-based) intervention, geared towards the patient and caregiver. Specifically, during Aim 1, the formative phase, investigators propose to further refine the newly developed intervention components with the help of an established patient/caregiver advisory board. The intervention, Recovery Support for Bladder Cancer (RSBC), consists of a pre-treatment, in-person preparatory instructional session with a trained health care professional (Module 1) to equip patients and caregivers with the skills to adjust to the upcoming treatment and recovery period. This is followed by a post-treatment, interactive web-based program (Module 2) to provide further support for both patients and caregivers to enhance quality of life (QOL) and reduce infections and nurse/ER visits. The RSBC intervention will be evaluated in a 12-month randomized controlled trial (Aim 2) among patients and caregiver dyads (N=287 initial; 238 final sample) against a time and attention comparison condition (the Facing Forward brochures). Primary outcomes for both patients and caregivers will be improved QOL, which is hypothesized to be significantly higher among participants randomized into RSBC. Secondary outcomes will be fewer infections and nurse-ER visits for patients randomized into RSBC. Aim 3 proposes moderator (i.e., age, gender, surgical diversion type) and mediator (i.e., patient activation, distress) analyses of intervention efficacy. Investigators hypothesize that RSBC will be significantly more successful among (a) older, (b) female participants, and (c) patients with a conduit diversion type. Elevated levels of patient activation (i.e., higher self-care knowledge, self-efficacy, lower distress) will mediate the intervention effects. Exploratory Aim 4 will examine the costs and potential savings associated with developing and implementing the RSBC intervention. Investigators hypothesize that initial development and implementation costs of RSBC will be offset by reduced nurse/ER visits. The scientific premise is strong and supported by an established theoretical framework, extensive pilot data and a rigorous application of clinical research methods. The proposed study is highly innovative, as it comprehensively addresses unmet needs of both patients and caregivers from pre- and (immediate) post-treatment to recovery. This is achieved through an innovative combination of in-person preparation and skill-building and web-based technology. If successful, RSBC has the potential to significantly change clinical care for patients and caregivers with BC.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer, Patient Engagement, Patient Empowerment, Ileal Conduit
Keywords
patient focused intervention, caregiver, Internet based information, recovery support, bladder cancer, urinary diversion, neobladder

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The RSBC intervention will be evaluated in a 12-month randomized controlled trial among patients and caregiver dyads (N=287 initial; 238 final sample) against a time and attention comparison condition that focuses on general wellness.
Masking
Care ProviderOutcomes Assessor
Masking Description
Participants will be randomized based on a randomization table developed by study statistician. Care providers are not informed of the assigned study condition. Patients complete assessments through Redcap survey. Data analyst will be blinded to the nature of the numerical assignment of intervention vs control condition.
Allocation
Randomized
Enrollment
238 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual care enhanced
Arm Type
Active Comparator
Arm Description
Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Bladder cancer patients & caregivers receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Intervention Type
Behavioral
Intervention Name(s)
Cancer Resource Information Support (CRIS)
Intervention Description
Intervention support is patient initiated and accessed as needed
Intervention Type
Behavioral
Intervention Name(s)
Usual Care Enhanced
Intervention Description
Usual care is enhanced with the addition of the NCI Facing Forward brochure
Primary Outcome Measure Information:
Title
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Description
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Time Frame
Baseline,
Title
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Description
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Time Frame
1 month
Title
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Description
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Time Frame
3 months
Title
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Description
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Time Frame
6 months
Title
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Description
The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
Time Frame
12 months
Title
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Description
The Caregiver Quality of Life Index-C
Time Frame
Baseline
Title
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Description
The Caregiver Quality of Life Index-C
Time Frame
1 month
Title
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Description
The Caregiver Quality of Life Index-C
Time Frame
3 months,
Title
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Description
The Caregiver Quality of Life Index-C
Time Frame
6 months,
Title
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
Description
The Caregiver Quality of Life Index-C
Time Frame
12 months,
Secondary Outcome Measure Information:
Title
Infection rate (biological factor)
Description
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Time Frame
1 month
Title
Infection rate (biological factor)
Description
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Time Frame
3 months
Title
Infection rate (biological factor)
Description
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Time Frame
6 months
Title
Infection rate (biological factor)
Description
Infection rate will be assessed through self-report and verified through electronic medical chart review for each patient
Time Frame
12 months
Title
Visiting Nurse/ER visits
Description
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Time Frame
1 month
Title
Visiting Nurse/ER visits
Description
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Time Frame
3 months
Title
Visiting Nurse/ER visits
Description
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Time Frame
6 months
Title
Visiting Nurse/ER visits
Description
Nurse or ER visits will be assessed through self-report and verified through electronic medical chart review
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Exploratory Cost Analysis
Description
Costs relative to the development, implementation & maintenance of the intervention and cost of post-treatment care from the medical and billing records.
Time Frame
6 months
Title
Exploratory Cost Analysis
Description
Costs relative to the development, implementation & maintenance of the intervention and cost of post-treatment care from the medical and billing records.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (a) male or female patients diagnosed with BC (b) undergoing bladder removal surgery and one of the following urinary diversions: 1) ileal conduit, 2) neobladder or 3) Indiana pouch. (c) did not need or completed neo-adjuvant chemotherapy, (d) able to communicate with ease in English Exclusion Criteria: (a) the caregiving relationship is temporary (e.g., an out-of-town relative provides temporary support) as stated by both patient and caregiver.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Diefenbach, PhD
Phone
516-600-1440
Email
mdiefenbach@northwell.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas Mistretta, MPH
Phone
516-600-1460
Email
tmistretta1@northwell.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Diefenbach, PhD
Organizational Affiliation
Northwell Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Northwell Health
City
Manhasset
State/Province
New York
ZIP/Postal Code
11030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas Mistretta, MPH
Phone
516-600-1460
Email
tmistretta1@northwell.edu
First Name & Middle Initial & Last Name & Degree
Michael Diefenbach, PhD
Facility Name
Fox Chase Cancer Center
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19111
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emmanuel Lapitan
Phone
215-728-4778
Email
emmanuel.lapitan@fccc.edu
First Name & Middle Initial & Last Name & Degree
Suzanne Miller, PhD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Recovery Support for Bladder Cancer Patients and Caregivers

We'll reach out to this number within 24 hrs